Abstract
Cyclosporine (1), originally named “Cyclosporin A” (for nomenclature see section 1.2), is the main component of a new family of cyclic peptides each comprising 11 amino acids. These peptides are produced as secondary fungal metabolites by Cylindrocarpon lucidum Booth and Tolypocladium inflatum Gams. Both strains of fungi imperfecti were isolated from soil samples collected in Wisconsin (USA) and Hardanger Vidda (Norway). The isolation, the culture conditions and the taxonomy of these fungi are reported by Dreyfuss et al. (1).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Dreyfuss, M., E. Haerri, H. Hoffmann, H. Kobel, W. Pache, and H. Tscherter: Cyclosporin A and C. New Metabolites from Trichoderma polysporum (Link ex Pers.) Rifai. Eur. J. Appl. Microbiol. 3, 125 (1976).
Borel, J.F., C. Feurer, H.U. Gubler, and H. Staehelin: Biological Effects of Cyclosporin A: A New Antilymphocytic Agent. Agents Actions 6, 468 (1976).
Borel, J.F.: Comparative Study of in vitro and in vivo Drug Effects on Cell-Mediated Cytotoxicity. Immunology 31, 631 (1976).
Borel, J.F., C. Feurer, C. Magnee, and H. Staehelin: Effects of the New AntiLymphocytic Peptide Cyclosporin A in Animals Immunology 32, 1017 (1977).
Borel, J.F., D. Wiesinger, and H.U. Gubler: Effects of the Antilymphocytic Agent Cyclosporin A in Chronic Inflammation. Europ. J. Rheumatol. Inflammation 1, 237 (1978).
Wiesinger, D., and J.F. Borel: Studies on the Mechanism of Action of Cyclosporin A Immunobiol. 156, 454 (1979).
Bueding, E., J. Hawkins, and Y.N. Cria: Antischistosomal Effects of Cyclosporin A. Agents Actions 11, 380 (1981).
Thommen-Scott, K.: Antimalarial Activity of Cyclosporin A. Agents Actions 11, 770 (1981).
Moms, P.J.: Cyclosporin A Overview. Transplantation 32, 349 (1981).
Morris, P.J.: The Impact of Cyclosporin A on Transplantation. Advances in Surgery 17, 99 (1984).
Calne, R.Y., D.J.G. White, S. Tiuru, D.B. Evans, P. Mcmaster, D.C. Dunn, G.N. Craddock, D.B. Pentlow, and K. Rolles: Cyclosporin A in Patients Receiving Renal Allografts from Cadaver Donors. Lancet ii, 1323 (1978).
Powles, R.L., A.J. Barrett, H. Clink, H.E.M. Kay, J. Sloane, and T.J. Mcelwain: Cyclosporin A for the Treatment of GVH-Disease in Man. Lancet ii, 1327 (1978).
Kahan, B.D., ed.: Cyclosporine, Biological and Clinical Applications. Orlando: Grune and Stratton 1984; or In: Transplantation Proceedings, Vol. XV, No. 4, suppl. 1 (December) p. 2207 (1983).
Schindler, R., ed.: Cyclosporin in Autoimmune Diseases. Berlin-Heidelberg: Springer. 1985.
Wenger, R.M.: Chemistry of Cyclosporin. In: Cyclosporin A. p. 19. Amsterdam: Elsevier Biomed. 1982.
Wenger, R.M.: Synthesis of Cyclosporine. I. Synthesis of Enantiomerically Pure (2S,3R,4R,6E)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoic Acid Starting from Tartaric Acid. HeIv. Chim. Acta 66, 2308 (1983).
Wenger, R.M.: Synthesis of Cyclosporine. Helv. Chim. Acta 67, 502 (1984).
Wenger, R.M.: Synthesis of Cyclosporine and Analogues: Structural Requirements for Immunosuppressive Activity. Angew. Chem. Intern. Ed. Engl. 24, 77 (1985).
IUPAC-IUB Joint Commission on Biochemical Nomenclature: Nomenclature and Symbolism for Amino Acids and Peptides, Recommendations 1983. Eur. J. Biochem. 138, 9 (1984).
Borel, J.F., ed.: Ciclosporin. Progress in Allergy, Vol. 38, p. 9. Basel: Karger. 1986.
Wenger, R.M., T.G. Payne, and M.H. Schreier: Cyclosporine Chemistry, Structure-Activity Relationships and Mode of Action. In: Progress in Clinical Biochemistry and Medicine, p. 157. Berlin-Heidelberg: Springer. 1986.
Rüegger, A., M. Kuhn, H. Lichti, H.R. Loosli, R. Huguenin, CH. Quiquerez, and A. von Wartburg: Cyclosporin A, ein immunosuppressiv wirksamer Peptidmetabolit aus Trichoderma polysporum (Link ex Pers.) Rifai. Helv. Chim. Acta 59, 1075 (1976).
Traber, R., M. Kuhn, A. Rüegger, H. Lichti, H.R. Loosli, and A. von Wartburg: Die Struktur von Cyclosporin C. Helv. C.im. Acta 60, 1247 (1977).
Traber, R., M. Kuhn, H.R. Loose, W. Pache, and A. von Wartburg: Neue Cyclopeptide aus Trichoderma polysporum (Link ex Pers.) Rifai: die Cyclosporine B, D und E. HeIv. Chim. Acta 60, 1568 (1977).
Traber, R., H.R. Loosli, H. Hofmann, M. Kuhnn, and A. von Wartburg: Isolierung und Strukturvermittlung der neuen Cyclosporine E, F, G, H und I. Helv. Chim. Acta 65, 1655 (1982).
Traber, R., H. Hofmann, H.R. Loosli, and A. von Wartburg: Cyclosporins, a New Group of Potent Immunoregulators - Structure Activity Relationships. 24th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington D.C., 8–10 Oct. 1984, Poster Presentation, Abstract No. 900.
von Wartburg A., and R. Traber: Chemistry of the Natural Cyclosporine Metabolites in Progress in Allergy, Vol. 38, p. 28. Basel: Karger. 1986.
Kobel, H., and R. Traber: Directed Biosynthesis of Cyclosporins. Eur. J. Appl. Microbiol. Biotechnol. 14, 237 (1982).
Petcher, T.J., H.P. Weber, and A. Ruegger: Crystal and Molecular Structure of an Iodo-Derivative of the Cyclic Undecapeptide Cyclosporin A. Helv. Chim. Acta 59, 1480 (1976).
Cambie, R.C., R.C. Hayward, J.L. Roberts, P.S. Rutledge: Diterpenes. Todocarboxylation of Phyllocladene and Isophyllocladene. J. Chem. Soc. Perkin I, 1, 1120 (1974).
Loosli, H.R., H. Kessler, H. Oschkinat, H.P. Weber, T.J. Petcher, and A. Widmer: The Conformation of Cyclosporin A in the Crystal and in Solution. Helv. Chim. Acta 68, 682 (1985).
Chou, P.Y., and G.D. Fasman: I3-Turns in Proteins. J. Mol. Biol. 115, 135 (1977).
Smith, J.A., and L.G. Pease: Reverse Turns in Peptides and Proteins. CRC Critical Reviews in Biochemistry 8, 315 (1980).
Richardson, J.S.: The Anatomy and Taxonomy of Protein Structure. Adv. Protein Chem. 34, 167 (1981).
Richardson, J.S.: A New Twist for Hairpin Turns. Nature 316, 102 (1985).
Pullman, B., and B. Maigret: In: Conformation of Biological Molecules and Polymers, p. 13. New York: Academic Press. 1973.
Kuhn, M., and R.M. Wenger: Dihydro-MeBmt Natural and Synthetic. Unpublished results.
Wenger, R.M.: N-BOC- and N-Z-isocyclosporine. Unpublished results.
Bollinger, P.: Iodination of Cyclosporine. Unpublished results.
Voges, R., B. von Wartburg, H.R. Loosli: Tritiated Compounds for in vivo Investigations. Second Intern. Symposium on the Synthesis and Application of Isotopically Labelled Compounds, Kansas City, Sept. 1985.
Gams, W.: Tolypocladium, eine Hyphomycetengattung mit geschwollenen Phialiden. Personia 6, 185 (1971).
Wood, A.J., G. Maurer, W. Niederberger, and T. Beveridge: Cyclosporine: Pharmacokinetics, Metabolism and Drug Interaction. Transplantation Proceedings 15 (Suppl. 1), 2409 (1983); (or Ref. 13, p. 193 ).
Maurer, G., H.R. Loosli, E. Sschreier, and B. Keller: Disposition of Cyclosporine in Several Animal Species and Man. I. Structural Elucidation of its Metabolites. Drug Metabolism and Disposition 12, 120 (1984).
Hartman, N.R., L.A. Trimble, J.C. Vederas, and I. Jardine: An Acid Metabolite of Cyclosporine. Biochem. Biophys. Res. Comm. 133, 964 (1985).
Hiestand, P., and B. Ryffel: Pharmacological Activity of Cyclosporine Metabolites. Unpublished results.
Kessler, H., H.R. Loosli, and H. Oschkinat: Peptide Conformations: Assignment of 1H, 13C, and 5N-NMR Spectra of Cyclosporin A in CDC13 and C6D6 by a Combination of Homo-and Heteronuclear Two-Dimensional Techniques. Helv. Chim. Acta 68, 661 (1985).
Donatsch, P., E. Abisch, M. Homberger, R. Traber, M. Trapp, and R. Voges: A Radioimmunoassay to Measure Cyclosporin A in Plasma and Serum Samples. J. Immunoassay 2, 19 (1981).
Quesniaux, V., R. Tees, M.H. Schreier, R.M. Wenger, P. Donatsch, M.H.V. van Regenmortel: Monoclonal Antibodies to Ciclosporin. In: Progress in Allergy, Vol. 38, p. 108 (1986).
Rosenthaler, J., P. Ball, and H. Münzer: Monoclonal Antibodies to Ciclosporin. Manuscript in preparation.
Quesniaux, V., R.M. Wenger, M.H. Schreier, and M.H.V. van Regenmortel: Manuscript in preparation.
Kobel, H., H.R. Loosli, and R. Voges: Contribution to Knowledge of the Biosynthesis of Cyclosporin A. Experientia 39, 873 (1983).
Zocher, R., and H. Kleinkauf: Biosynthesis of Enniatin B. Partial Purification and Characterization of the Synthesizing Enzyme and Studies of the Biosynthesis. Biochem. Biophys. Res. Comm. 81, 1162 (1978).
Zocher, R., N. Madry, H. Peeters, and H. Kleinkauf: Biosynthesis of Cyclosporin A. Phytochemistry 23, 549 (1984).
Siegbahn, N., K. Mosbach, K. Grodzki, R. Zocher, N. Madry, and H. Kleinkauf: Covalent Immobilization of the Multienzyme Enniatin Synthetase. Biotechnology Letters 7, 297 (1985).
Zocher, R., U. Keller, and H. Kleinkauf: Enniatin Synthetase, a Novel Type of Multifunctional Enzyme Catalysing Depsipeptide Synthesis in Fusarium oxysporum. Biochemistry 21, 43 (1982).
Zocher, R., T. Nihira, E. Paul, N. Madry, H. Peeters, H. Kleinkauf, and U. Keller: Biosynthesis of Cyclosporin A: Partial purification and Properties of a Multifunctional Enzyme from: Tolypocladium inflatum. Biochemistry 25, 550 (1986).
Schlosser, M., and K.F. Christmann: Mechanismus und Stereochemie der Wittig-Reaktion. Justus Liebigs Ann. Chem. 708, 1 (1967).
Seeley, D.A., J. Mcelwee: Stereospecific Synthesis of cis and trans Epoxides from the Same Diol. J. Org. Chem 38, 1691 (1973).
Herb, R.W., D.M. Wieland, and C.R. Johnson: Reactions of Organocopper Reagents with Oxiranes. J. Amer. Chem. Soc. 92, 3813 (1970).
Pfitzner, K.E., and J.G. Moffarr: Sulfoxide-Carbodiimide Reactions. Scope of the Oxidation Reaction. J. Amer. Chem. Soc. 87, 5670 (1965).
Wenger, R.M.: Synthesis of Cyclosporine. Hely. Chim. Acta 66, 2672 (1983).
Mcderniorr, J.R., and N.L. Benoiton: (a) N-methylamino Acids in Peptide Synthesis. Razemization During Deprotection by Saponification and Acidolysis. Can. J. Chem. 51, 2551 (1973); (b) Razemization and Yields in Peptide-Bond Formation. Can. J. Chem. 51, 2562 (1973).
Tung, R.D., and D.H. Rich: Bis(2-oxo-3-oxazolidinyl)phosphinic Chloride as a Coupling Reagent for N-alkyl Amino Acids. J. Amer. Chem. Soc. 107, 4342 (1985).
Zaoral, M.: Amino Acids and Peptides. Pivaloyl Chloride as a Reagent in the Mixed Anhydride Snthesis of Peptides. Collect. Czech. Chem. Commun. 27, 1273 (1962).
Koenig, W., and R. Geiger: Eine neue Methode zur Synthese von Peptiden. Aktivierung der Carboxylgruppe mit DCCI unter Zusatz von 1-Hydroxybenztriazolen. Chem. Ber. 103, 788 (1970).
Castro, B., J.R. Doaatoy, G. Evin, and C. Selve: Réactifs de couplage peptidique. L’hexafluorophosphate de benzotriazolyl-N-oxytrisdimethyl-aminophosphonium (BOP). Tetrahedron Lett. 14, 1219 (1975).
Wissmann, H., and H.J. Kleiner: Neue Peptidsynthese. Angew. Chem. 92, 129 (1980); Angew. Chem. Int. Ed. Engl. 19, 133 (1980).
Kovacs, J.: In: The Peptides, Vol. 2, p. 485. New York: Academic Press. 1980.
Wenger, R.M.: Synthesis of Cyclosporine and Analogues: Structure Activity Relationships of New Cyclosporine Derivatives. Transplantation Proceedings, Vol. XV, No. 4, Suppl. 1, 2230 (1983).
Seebach, D., W. Murtiasiiaw, R. Naef, S.I. Shoda (ETH Zürich), and M. Krieger, P. Bollinger, A. Leutwiler, and R. Wenger (Sandoz Ltd.): Aktive CyclosporinDerivate durch C-Alkylierung unter Ersatz von H’ der Sarkosin-Einheit. Erzeugung Polythiierter Peptide. Work presented at the autumn session of the Swiss Chemical Society in Berne (October 18, 1985). Manuscript in preparation.
Borel, J.F., and B. Ryffel: The Mechanism of Action of Ciclosporin, a Continuing Puzzle. In: Ciclosporin in Autoimmune Diseases, p. 24. Berlin-Heidelberg-New York: Springer. 1985.
Hess, A.D., and P.M. Colombani: Mechanism of Action, in vitro Studies. In: Progress in Allergy, Vol. 38, p. 198. Basel: Karger. 1986.
Larson, D.F.: Mechanism of Action, Antagonism of the Prolactin Receptor. In: Progress in Allergy, Vol. 38, p. 222. Basel: Karger. 1986.
Hiestand, P.C., and P. Meckler: Mechanism of Action, Ciclosporin-and ProlactinMediated Control of Immunity In Progress in Allergy, Vol. 38, p. 239. Basel: Karger. 1986.
Schreier, M.H.: Interleukin-2 and its Role in the Immune System. Triangle 23, 141 (1984).
Batchelor, J.R.: Genetic Role in Autoimmunity. In: Ciclosporin in Autoimmune Diseases, p. 24. Berlin-Heidelberg-New York: Springer. 1985.
Morgan, D.A., F.W. Ruscetti, and R. Gallo: Selective in vitro Growth of T-Lymphocytes from Normal Human Bone Marrow. Science 193, 1007 (1976).
Bunjes, D., C. Hardt, M. Roellinghoff, and H. Wagner: Cyclosporin A Mediates Immunosuppression of Primary Cytotoxic T Cell Responses by Impairing the Release of Interleukin 1 and Interleukin 2. Europ. J. Immunol. 11, 657 (1981).
Ryffel, B., U. Goetz, and B. Heuberger: Cyclosporin Receptors on Human Lymphocytes. J. Immunol. 129, 1978 (1982).
Miyawaki, T., A. Yachie, S. Oxzeki, T. Nagaoki, and N. Taniguchi: Cyclosporin A Does not Prevent Expression of Tac Antigen, a Probable TCGF Receptor Molecule, on Mitogen-Stimulated Human T Cells. J. Immunol. 130, 2737 (1983).
Kunkl, A., and G.G.B. Klaus: Selective Effects of Cyclosporin A on Functional B Cell Subsets in the Mouse. J. Immunol. 125, 2526 (1980).
Kroenke, M., W.J. Leonhard, J.M. Depper, S.K. Arya, F. Wong-Staal, R.C. Gallo, T.A. Waldmann, and W.C. Greene: Cyclosporin A Inhibits T-Cell Growth Factor Gene Expression at the Level of mRNA Transcription. Proc. Nat. Acad. Sci. USA 81, 5214 (1984).
Handschumacher, R.E., M.W. Hardy, J. Rich, R.J. Drugge, and D.W. Speicher: Cyclosphilin: a Specific Cytosolic Binding Protein for Cyclosporin A. Science 226, 544 (1984).
Harding, M.W., R.E. Handschumacher, and D.W. Speicher: Isolation and Amino Acid Sequence of Cyclophilin J Biol. Chem. 261, 8547 (1986).
Colombani, P.M., A. Robb, and A.D. Hess: Cyclosporin A binding to Calmodulin: a Possible Site of Action on T-Lymphocytes. Science 228, 337 (1985).
Hass, A.D., T. Tuszynski, P. Engel, P.M. Colombani, J. Farrington, R. Wenger, and B. Ryffel: Intracellular and Nuclear Localization of Cyclosporine and Peripheral Blood Mononuclear Cells. Transplant. Proc. 18, 861 (1986).
Hiestand, P. (Sandoz Basel), A.D. Hass (Baltimore), and R.E. Handschumacher (New Haven): Unpublished Results, personal communication.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag/Wien
About this chapter
Cite this chapter
Wenger, R.M. (1986). Cyclosporine and Analogues — Isolation and Synthesis — Mechanism of Action and Structural Requirements for Pharmacological Activity. In: Herz, W., Grisebach, H., Kirby, G.W., Tamm, C. (eds) Fortschritte der Chemie organischer Naturstoffe / Progress in the Chemistry of Organic Natural Products. Fortschritte der Chemie organischer Naturstoffe / Progress in the Chemistry of Organic Natural Products, vol 50. Springer, Vienna. https://doi.org/10.1007/978-3-7091-8888-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-7091-8888-0_4
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-8890-3
Online ISBN: 978-3-7091-8888-0
eBook Packages: Springer Book Archive